Consistently, PQQ was able to increase GSH expression and Gpx4 activity in cardiomyocytes in vivo and in vitro, in addition to augmenting the FSP1-CoQ10 axis to protect against ferroptosis-associated damage
A.SakrE
Whether these molecules will become game changers is a question not likely to be answered until the first ones hit the market
The body does not mount the same defensive downregulation because the signaling patterns mimic endogenous processes
Pemafibrate and fenofibrate (PPAR- agonists) have been approved for the treatment of dyslipidemia, atherosclerosis, and T2DM, effectively lowering blood lipids and improving metabolic conditions in individuals with diabetes
Vallance HD, Koochin A, Branov J, Rosen-Heath A, Bosdet T, Wang Z, Hazen SL, Horvath G